ArticleOncoTargets and therapy2015

Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer.

Xiao-Qing Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.